Vital Signs: Prognosis: Testosterone and Prostate Cancer
Monday, April 25, 2011 - 12:30
in Health & Medicine
The researchers looked at men with the cancer who received testosterone therapy for an average of two and a half years. None of their cancers progressed or spread to other organs.